Understanding Sleep and Activity After Transplant
This study is looking at how sleep and physical activity change for patients and their caregivers after an allogeneic hematopoietic cell transplant (a type of stem cell transplant). You and your caregiver would wear a Fitbit device to track your activity, sleep, and heart rate. You'll also complete questionnaires at three different times: when you enroll, 8 days after your transplant, and 7 days after you leave the hospital. The main goal is to see if it's practical to collect this information using Fitbits and to understand how these changes affect your quality of life. This study is for patients aged 18 and older who are scheduled for an allogeneic HCT for a blood cancer, and their primary caregivers. The study aims to enroll 66 participants.
- Study design
- This is an observational study, meaning researchers will collect information without giving any specific treatment. It plans to include 66 participants.
- What's involved
- You would wear a Fitbit device on your wrist and complete questionnaires at three different times: enrollment, 8 days after transplant, and 7 days after hospital discharge. You will also complete two functional tests, including a grip strength test.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your quality of life will be measured through study completion, which is an average of 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation
At a glance
Conditions
NCT07140770
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
MD Anderson Cancer Center
Houston, Texasstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Eileen D Hacker, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Exclusion
What this trial measures
- Quality of Life QuestionnaireThrough study completion; an average of 1 year
You will answer questionnaires with a member of the research team. The questionnaires will take about 35 minutes complete. You will be asked questions about your sleep, anxiety and depressive symptoms, fatigue, distress, and your quality of life.